A massive study of 11 million US veterans found that people with untreated sleep apnea were nearly twice as likely to develop Parkinson’s disease — and that a simple breathing machine worn at night may cut that risk by nearly a third.
Story Snapshot
- Untreated obstructive sleep apnea was linked to a 92% higher risk of developing Parkinson’s disease in a landmark study published in JAMA Neurology in January 2026.
- Veterans who used a CPAP machine within two years of their sleep apnea diagnosis had a 30% lower risk of developing Parkinson’s disease.
- Women with sleep apnea faced four times the Parkinson’s risk compared to men — a finding researchers have not yet fully explained.
- The study is observational, meaning it shows a strong link but cannot yet prove that sleep apnea directly causes Parkinson’s disease.
The Study That Changed the Conversation
Researchers at Oregon Health and Science University examined electronic health records from the US Department of Veterans Affairs spanning 1999 to 2022. The dataset covered more than 11 million veterans. They found that patients with untreated obstructive sleep apnea — a condition where breathing repeatedly stops during sleep — developed Parkinson’s disease at nearly double the rate of those who treated their sleep apnea with a continuous positive airway pressure machine, commonly called a CPAP. The hazard ratio was 1.92, with tight confidence intervals that ruled out random chance.
The diagnostic methods held up under scrutiny. Researchers validated their process with chart reviews and found a 94% accuracy rate for identifying sleep apnea cases and a 79% accuracy rate for Parkinson’s disease cases. Those are strong numbers for a records-based study of this size. The team also adjusted for diabetes, high blood pressure, vascular disease, depression, anxiety, body mass index, and even how often patients used the health care system — and the link held firm.
A CPAP Machine Might Do More Than Help You Sleep
The treatment finding is where this study gets genuinely exciting. Veterans who started using a CPAP machine within two years of their sleep apnea diagnosis were 30% less likely to develop Parkinson’s disease compared to those who went untreated. That is not a trivial number. Parkinson’s disease affects more than one million Americans and has no cure. If a breathing device worn at night could meaningfully reduce the odds of developing it, that is a public health finding worth taking seriously — even before causation is proven.
There is a catch worth knowing. Only 9% of sleep apnea patients in the study were documented as using a CPAP machine. That small group limits how confident researchers can be about the 30% risk reduction. A larger treated population would produce a more reliable estimate. Still, the direction of the finding is hard to ignore, and it lines up with a plausible biological story: repeated oxygen drops during sleep may damage brain cells through inflammation and mitochondrial stress, potentially triggering the kind of protein buildup seen in Parkinson’s disease.
The Women’s Risk Finding Demands Attention
Women with sleep apnea in this study had four times the odds of developing Parkinson’s disease compared to men. That gap is enormous and unexplained. Sleep apnea is historically underdiagnosed in women because their symptoms often look different — less snoring, more fatigue and insomnia. Women may be going longer without diagnosis or treatment, which could partly explain the higher risk. Hormonal differences and genetic factors likely play a role too. Researchers have called for a dedicated sex-specific analysis, and that work cannot come fast enough.
What the Study Cannot Tell Us Yet
The researchers themselves are clear about the limits. This is an observational study, which means it tracks patterns — it does not run a controlled experiment. One legitimate concern is reverse causation: early Parkinson’s disease can disturb sleep, which might lead to a sleep apnea diagnosis, rather than the other way around. The study also found that the severity of sleep apnea did not change the odds of developing Parkinson’s disease — only the timing. That is a puzzle. If oxygen deprivation is the mechanism, you would expect worse apnea to produce worse outcomes.
These are real limitations, not reasons to dismiss the findings. The counter-evidence from skeptics amounts to methodological caution, not a competing dataset that disproves the association. No published study has produced specific numbers that rebut the 1.92 hazard ratio or the CPAP treatment effect. The scientific burden now falls on prospective trials — studies that follow patients forward in time with verified diagnoses — to confirm what this massive retrospective study strongly suggests. Until then, the association stands as the best available evidence, and it is strong enough to act on.
What This Means for Anyone With Sleep Apnea
Roughly 30 million Americans have obstructive sleep apnea, and many go undiagnosed for years. The traditional reasons to treat it — better sleep, lower blood pressure, reduced heart risk — were already compelling. This study adds a neurological reason to the list. Getting screened, getting diagnosed, and actually using a CPAP machine if prescribed now carries implications that extend well beyond a good night’s rest. The mainstream neurology establishment has not yet endorsed sleep apnea as an official Parkinson’s risk factor, but the evidence is moving in one direction, and it is moving fast.
Sources:
youtube.com, news.ohsu.edu, hmpgloballearningnetwork.com
